The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury

Yale Journal of Biology and Medicine

Volumn 70, Issue 4, 1997, Pages 391-402

  Bruck, Rafael ^a,b   Hershkoviz, Rami ^c   Lider, Ofer ^c   Shirin, Haim ^a,b   Aeed, Hussein ^a,b   Halpern, Zamir ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ARGINYLGLYCYLASPARTIC ACID; COLLAGEN; CONCANAVALIN A; DRUG ANALOG; EPITOPE; GLYCOPROTEIN; INTEGRIN; LAMININ; PROTEOGLYCAN; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VERY LATE ACTIVATION ANTIGEN; VITRONECTIN;

CELL ADHESION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; HEPATITIS; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER FIBROSIS; LIVER INJURY; NONHUMAN; ORAL DRUG ADMINISTRATION;

ANIMALS; ANTIGENS, CD29; CELL ADHESION; DISEASE MODELS, ANIMAL; GUANIDINES; HUMANS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER DISEASES; MICE; OLIGOPEPTIDES; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VALERATES;

EID: 0031393744     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Springer, T.A. Adhesion receptors of the immune system. Nature 346:425-434, 1990.
2. Hynes, R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992.
3. Ruoslahti, E. Integrins. J. Clin. Invest. 87:1-5, 1991.
4. Ruoslahti, E. Fibronectin and its receptors. Ann. Rev. Biochem. 57:375-393, 1988.
5. D'Souza, S.E., Ginsberg, M.H., and Plow, E.F. Arginyl-Glycyl-Aspartic acid (RGD): a cell adhesion motif. TIBS 16:246-50, 1991.
6. Shimuzu, Y., van Seventer, G.A., Horgan, K.J., and Shaw, S. Regulated expression and binding of three VLA (β1) integrin receptors on T-cells. Nature 345:250-253, 1990.
7. Ferguson, T.A., Mizutani, H., and Kupper, T.S. Two integrin-binding peptides abrogate T-cell-mediated immune responses in vivo. Proc. Natl. Acad. Sci. U.S.A. 88:8072-8076, 1991.
8. Greenspoon, N., Hershkoviz, R., Alon, R., Varon, D., Shemkman, B., Marx, G., et al. Selective inhibition of integrin-mediated platelet and T-cell function by novel organic surrogates of the Arg-Gly-Asp cell adhesion motif. Biochem. 32:1001-1008, 1993.
9. + T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by novel peptidic mimetics of the Arg-Gly-Asp cell adhesion motif. Clin. Exp. Immunol. 95:270-276, 1994.
10. Hardan, I., Hershkoviz, R. Greenspoon, N., Weiss, L., Alon, R., Cahalon, L., et al. Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by nonpeptidic mimetics of the Arg-Gly-Asp motif. Int. J. Cancer 55:1-6, 1993.
11. Tiegs, G., Hentchel, J., and Wendel, A. A T-cell-dependent experimental liver injury in mice inducible by Concanavalin A. J. Clin. Invest. 90:196-203, 1992.
12. Gantner, F., Leist, M., Lohse, A.W., Germann, P.G., and Tiegs, G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatol. 21:190-198, 1995.
13. Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., et al. T-cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179:1529-1537, 1994.
14. Watanabe, Y., Morita, M., and Akaike, T. Concanavalin A induces perforin-mediated but not Fasmediated hepatic injury. Hepatol. 24:702-710, 1996.
15. Hershkoviz, R., Lider, O., Bruck, R., Aeed, H., Greenspoon, N., and Halpern, Z. Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope. J. Hepatol. 22:158-164, 1995.
16. Bruck, R., Shirin, H., Hershkoviz, R., Lider, O., Kenet, G., Aeed, H., Matas, Z., Zaidel, L., and Halpern, Z. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumor necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice. Gut 40:133-138, 1997.
17. Horn, T., Junge, J., and Christofferson, P. Early alcoholic liver injury: activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J. Hepatol. 3:333-340, 1986.
18. 1 with hepatic fibrogenesis. J. Cell Biol. 108:2477-2482, 1989.
19. Milani, S., Schuppan, D., Herbst, H., and Surrenti, C. Expression of transforming growth factor β1 in normal and fibrotic human liver. In: A.M. Gressner, G. Ramadori, eds. Molecular and Cell Biology of Liver Fibrogenesis. Dordrecht: Kluwer Academic Publishers, 1992. pp. 254-261.
20. Kagami, S., Border, W.A., Ruoslahti, E., and Noble, N.A. Coordinated expression of β1 integrins and transforming growth factor-β-induced matrix proteins in glomerulonephritis. Lab. Invest. 69:68-76, 1993.
21. Schif, E.R. Hepatic fibrosis - new therapeutic approaches. N. Engl. J. Med. 324:987-988, 1991.
22. Muller, A., Machnik, F., Zimmermann, T., and Schubert, H. Thioacetamide-induced cirrhosis-like lesions in rats - usefulness and reliability of this animal model. Exp. Pathol. 34:229-236, 1988.
23. Bruck, R., Hershkoviz, R., Lider, O., Aeed, H., Zaidel, L., Matas, Z., Barg, J., and Halpern, Z. Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope. J. Hepatol. 24:731-738, 1996.
24. Chevallier, M., Guerret, S., Chossegros, P., Gerard, F., and Grimaud, J.A. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle biopsy specimens: comparison with morphometric studies. Hepatol. 20:349-355, 1994.
25. Nuber, R., Teutsch, H.F., and Sasse, D. Metabolic zonation in thioacetamide-induced liver cirrhosis. Histochemistry 69:277-288, 1980.
26. Pinzani, M., Gesualdo, L., Sabbah, G.M., and Abboud, H.E. Effects of platelet derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat storing cells. J. Clin. Invest. 84:1786-1793, 1989.
27. 1 in human fat-storing cells. Gastroenterol. 105:245-253, 1993.
28. Clement, B., Loreal, O., Rescan, P.Y., Levavasseur, F., Diakonova, M., Rissel, M., L'Helgoualc'h, A., and Guillouzo, A. Cellular origin of the hepatic extracellular matrix. In: Gressner, A.M., Ramadori, G., eds. Molecular and Cell Biology of Liver Fibrogenesis. Dordrecht: Kluwer Academic Publishers, 1992. pp. 85-98.
29. Ried, M.L., Florino, A.S., Sigal, S.H., Brill, S., and Holst, P.A. Extracellular matrix gradients in the space of Disse: relevance to liver biology. Hepatol. 15:1198-1203, 1992.
30. Friedman, S.L., Roll, F.J., Boyles, J., Arenson, D.M. and Bissel, D.M. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J. Biol. Chem. 264:10756-10762, 1989.
31. Brown, L.F., Dubin, J., Lavigne, L., Logan, B., Dvork, H.F., and Vandewater, L. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am. J .Pathol. 142:793-801, 1993.
32. Barnes, J.L., Hastings, R.R., and De La Garza, M.A. Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells proliferative glomerulonephritis. Am. J. Pathol. 145:585-597, 1994.
33. 4 induced cirrhosis. Lab. Invest. 53:166-186, 1985.
34. Hershkoviz, R., Melamed, S., Greenspoon, N., and Lider, O. Nonpeptidic analogues of the Arg-Gly-Asp (RGD) sequnce specifically inhibit the adhesion of human tenon's capsule fibroblasts to fibronectin. Invest. Ophtalmol. Vis. Sci. 35:2585-2591, 1994.
35. 1 integrin subunits during activation of hepatic stellate cells. Gastroenterol. 112:A1331, 1997.
36. + T-cells and macrophages. Immunol. 78:50-57, 1993.
37. Hershkoviz, R., Alon, R., Gilat, D., and Lider, O. Activated T-lymphocytes and macrophages secrete fibronectin which strongly support cell adhesion. Cell. Immunol. 141:352-361, 1992.
38. Salo, T., Turpeenniemi-Hujansen, T., and Tryggvason, K. Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (Type IV) collagen-degrading metalloproteinases by human fibroblasts. J. Biol. Chem. 260:8526-8531, 1985.